<bill session="108" type="sc" number="80" updated="2023-01-15T09:17:40Z">
  <state datetime="2003-11-10">REFERRED</state>
  <status>
    <introduced datetime="2003-11-10"/>
  </status>
  <introduced datetime="2003-11-10"/>
  <titles>
    <title type="display">A concurrent resolution urging Japan to honor its commitments under the 1986 Market-Oriented Sector-Selective (MOSS) Agreement on Medical Equipment and Pharmaceuticals, and for other purposes.</title>
    <title type="official" as="introduced">A concurrent resolution urging Japan to honor its commitments under the 1986 Market-Oriented Sector-Selective (MOSS) Agreement on Medical Equipment and Pharmaceuticals, and for other purposes.</title>
  </titles>
  <sponsor bioguide_id="C001057"/>
  <cosponsors>
    <cosponsor bioguide_id="B001233" joined="2003-11-10"/>
    <cosponsor bioguide_id="G000445" joined="2004-01-22"/>
    <cosponsor bioguide_id="S000059" joined="2004-02-09"/>
  </cosponsors>
  <actions>
    <action datetime="2003-11-10">
      <text>Introduced in Senate</text>
    </action>
    <action datetime="2003-11-10" state="REFERRED">
      <text>Read twice and referred to the Committee on Foreign Relations.</text>
      <reference ref="CR S14364" label="text of measure as introduced"/>
    </action>
  </actions>
  <committees>
    <committee code="SSFR" name="Senate Foreign Relations" subcommittee="" activity="Referral"/>
  </committees>
  <relatedbills>
    <bill session="108" type="hc" number="324" relation="identical"/>
  </relatedbills>
  <subjects>
    <term name="International affairs"/>
    <term name="Access to health care"/>
    <term name="Administrative procedure"/>
    <term name="Commerce"/>
    <term name="Drug approvals"/>
    <term name="Drugs"/>
    <term name="East Asia"/>
    <term name="Foreign Trade and International Finance"/>
    <term name="Health"/>
    <term name="International competitiveness"/>
    <term name="Japan"/>
    <term name="Law"/>
    <term name="Medical economics"/>
    <term name="Medical innovations"/>
    <term name="Medical supplies"/>
    <term name="Medical technology"/>
    <term name="Nontariff trade barriers"/>
    <term name="Prescription pricing"/>
    <term name="Science, Technology, Communications"/>
    <term name="Technological innovations"/>
    <term name="Trade agreements"/>
  </subjects>
  <amendments/>
  <summary date="2003-12-22T22:18:40Z" status="Introduced in Senate">Urges Japan to honor its commitments under the Market-Oriented Sector-Selective (MOSS) Agreement on Medical Equipment and Pharmaceuticals by: (1) reducing regulatory barriers to the approval and adoption of new medical technologies; (2) establishing reasonable agency performance goals for premarket approvals and an appropriate, risk-based postmarket system consistent with globally accepted practices; (3) actively promoting pricing policies that encourage innovation; (4) implementing fair and open processes and rules that do not disproportionately harm United States medical technology products; and (5) providing opportunities for consultation with trading partners.</summary>
</bill>
